Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7166 p373-376
22 September 2001

This article
Reprint
Photocopy


News summary


Ocular toxicity in babies unlikely to be caused by two rheumatology drugs

Chloroquine and hydroxychloroquine do not appear to cause ocular toxicity in the babies of women given either drug while pregnant.

Dr Gil Klinger, department of paediatrics, Hospital for Sick Children, Toronto, and colleagues report this finding in a letter to The Lancet (2001;358:813).

Although it is rare, both chloroquine and hydroxychloroquine have been reported to cause visual defects, and a link between intrauterine exposure to chloroquine and retinal abnormalities has been made.

Dr Klinger and colleagues performed detailed ophthalmological examinations on 21 children who had been exposed to either drug in utero for an average of 7.2 months and compared the findings with reported normal results.

Visual acuity was normal for age in all examined children and no ophthalmological abnormalities were detected.

“The absence of visual abnormalities and other birth defects suggests that when chloroquine or hydroxychloroquine are required to control symptoms of rheumatological disease in pregnant women, the risk to benefit ratio is favourable,” they say. However, they add that a large follow-up study is needed to confirm the findings.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal